H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.

H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.

BACKGROUND: We investigated antibody persistence in children 1 year after 2 doses of either an AS03(B)-adjuvanted split-virion or nonadjuvanted whole-virion monovalent pandemic influenza vaccine and assessed the immunogenicity and reactogenicity of a subsequent dose of trivalent influenza vaccine (...

书目详细资料
Main Authors:	Walker, W, de Whalley, P, Andrews, N, Oeser, C, Casey, M, Michaelis, L, Hoschler, K, Harrill, C, Moulsdale, P, Thompson, B, Jones, C, Chalk, J, Kerridge, S, John, T, Okike, I, Ladhani, S, Tomlinson, R, Heath, P, Miller, E, Faust, SN, Snape, MD, Finn, A, Pollard, A
格式:	Journal article
语言:	English
出版:	2012

相似书籍

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.
由: Andrews, N, et al.
出版: (2011)

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
由: Andrews, N, et al.
出版: (2011)

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
由: Andrews, N, et al.
出版: (2011)

Relationships between reactogenicity and age, dose number and immunogenicity in 937 children receiving two doses of ASO3(B)-adjuvanted split virion or whole virus H1N1 influenza A 2009 pandemic vaccines
由: Walker, W, et al.
出版: (2011)

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.
由: de Whalley, P, et al.
出版: (2011)

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
由: de Whalley, P, et al.
出版: (2011)

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.
由: de Whalley, P, et al.
出版: (2011)

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
由: P de Whalley, et al.
出版: (2011-12-01)

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
由: Waddington, C, et al.
出版: (2010)

Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study
由: Waddington, C, et al.
出版: (2010)

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.
由: Waddington, C, et al.
出版: (2010)

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
由: CS Waddington, et al.
出版: (2010-10-01)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
由: Lambe, T, et al.
出版: (2012)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine
由: Lambe, T, et al.
出版: (2012)

Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later.
由: Hoschler, K, et al.
出版: (2014)

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.
由: Leroux-Roels, I, et al.
出版: (2009)

Antibody persistence and booster responses to Split-Virion H5N1 avian Influenza vaccine in young and elderly adults
由: Lazarus, R, et al.
出版: (2016)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
由: Alycia P. Fratzke, et al.
出版: (2022-05-01)

Pandemic influenza A (H1N1) 2009 vaccination in children: a UK perspective.
由: de Whalley, P, et al.
出版: (2013)

Pandemic influenza A (H1N1) 2009 vaccination in children: A UK perspective
由: De Whalley, P, et al.
出版: (2013)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
由: Shaw, RH, et al.
出版: (2021)

Methods for predicting vaccine immunogenicity and reactogenicity
由: Patrícia Gonzalez-Dias, et al.
出版: (2020-02-01)

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.
由: Snape, MD, et al.
出版: (2010)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial.
由: Diggle, L, et al.
出版: (2006)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
由: Diggle, L, et al.
出版: (2006)

Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.
由: Rajeka Lazarus, et al.
出版: (2016-01-01)

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action
由: Barker, C, et al.
出版: (2013)

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.
由: Barker, C, et al.
出版: (2014)

Reactogenicity of various COVID-19 vaccination regimens
由: O. M. Drapkina, et al.
出版: (2023-01-01)

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
由: Jeppesen, C, et al.
出版: (2015)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
由: Jisun Lee, et al.
出版: (2023-07-01)

Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: a randomized controlled trial in infants
由: Valente Pinto, M, et al.
出版: (2020)

Standardized guinea pig model for Q fever vaccine reactogenicity.
由: Laurie A Baeten, et al.
出版: (2018-01-01)

A randomized trial assessing the immunogenicity and reactogenicity of two hexavalent infant vaccines concomitantly administered with group b meningococcal vaccine
由: Rajan, M, et al.
出版: (2022)

Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines
由: David J. M. Lewis, et al.
出版: (2015-01-01)

Editorial: Non-reactogenic vaccines against Q-fever
由: Anthony E. Gregory, et al.
出版: (2023-05-01)

Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
由: Salma Al Bahrani, et al.
出版: (2021-09-01)

Influence of the reactogenity of the tick-borne encephalitis vaccines on the immune response in vaccinated people
由: G. N. Leonova, et al.
出版: (2006-12-01)

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)
由: Yu. H. Khapchaev, et al.
出版: (2017-06-01)

Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
由: João L Miraglia, et al.
出版: (2011-01-01)